 |
1FM6 |
THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND ROSIGLITAZONE AND CO-ACTIVATOR PEPTIDES. |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1FM9 |
THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND GI262570 AND CO-ACTIVATOR PEPTIDES. |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1GWQ |
HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1GWR |
HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-OESTRADIOL AND TIF2 NRBOX3 PEPTIDE |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1K4W |
X-ray structure of the orphan nuclear receptor ROR beta ligand-binding domain in the active conformation |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1K74 |
The 2.3 Angstrom resolution crystal structure of the heterodimer of the human PPARgamma and RXRalpha ligand binding domains respectively bound with GW409544 and 9-cis retinoic acid and co-activator peptides. |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1K7L |
The 2.5 Angstrom resolution crystal structure of the human PPARalpha ligand binding domain bound with GW409544 and a co-activator peptide. |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1L2I |
Human Estrogen Receptor alpha Ligand-binding Domain in Complex with (R,R)-5,11-cis-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol and a Glucocorticoid Receptor Interacting Protein 1 NR box II Peptide |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1M2Z |
Crystal structure of a dimer complex of the human glucocorticoid receptor ligand-binding domain bound to dexamethasone and a TIF2 coactivator motif |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1MV9 |
Crystal Structure of the human RXR alpha ligand binding domain bound to the eicosanoid DHA (Docosa Hexaenoic Acid) and a coactivator peptide |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1MVC |
Crystal structure of the human RXR alpha ligand binding domain bound to the synthetic agonist compound BMS 649 and a coactivator peptide |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1MZN |
CRYSTAL STRUCTURE at 1.9 ANGSTROEMS RESOLUTION OF THE HOMODIMER OF HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO THE SYNTHETIC AGONIST COMPOUND BMS 649 AND A COACTIVATOR PEPTIDE |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1N4H |
Characterization of ligands for the orphan nuclear receptor RORbeta |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1NQ7 |
Characterization of ligands for the orphan nuclear receptor RORbeta |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1NRL |
Crystal Structure of the human PXR-LBD in complex with an SRC-1 coactivator peptide and SR12813 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1OSV |
STRUCTURAL BASIS FOR BILE ACID BINDING AND ACTIVATION OF THE NUCLEAR RECEPTOR FXR |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1PZL |
Crystal structure of HNF4a LBD in complex with the ligand and the coactivator SRC-1 peptide |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1RDT |
Crystal Structure of a new rexinoid bound to the RXRalpha ligand binding doamin in the RXRalpha/PPARgamma heterodimer |
E |
D |
Nuclear receptor ligand-binding domain |
|
 |
1RJK |
crystal structure of the rat vitamin D receptor ligand binding domain complexed with 2MD and a synthetic peptide containing the NR2 box of DRIP 205 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1RK3 |
crystal structure of the rat vitamin D receptor ligand binding domain complexed with 1,25-dihydroxyvitamin D3 and a synthetic peptide containing the NR2 box of DRIP 205 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1RKG |
crystal structure of the rat vitamin D receptor ligand binding domain complexed with 2MbisP and a synthetic peptide containing the NR2 box of DRIP 205 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1RKH |
crystal structure of the rat vitamin D receptor ligand binding domain complexed with 2AM20R and a synthetic peptide containing the NR2 box of DRIP 205 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T5Z |
Crystal Structure of the Androgen Receptor Ligand Binding Domain (LBD) with DHT and a peptide derived from its physiological coactivator ARA70 |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T63 |
Crystal Structure of the Androgen Receptor Ligand Binding Domain with DHT and a peptide derived from its physiological coactivator GRIP1 NR box3 |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T65 |
Crystal structure of the androgen receptor ligand binding domain with DHT and a peptide derived form its physiological coactivator GRIP1 NR box 2 bound in a non-helical conformation |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T73 |
Crystal structure of the androgen receptor ligand binding domain in complex with a FxxFF motif |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T74 |
Crystal structure of the androgen receptor ligand binding domain in complex with a WxxLF motif |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T76 |
Crystal structure of the androgen receptor ligand binding domain in complex with a WxxVW motif |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T79 |
Crystal structure of the androgen receptor ligand binding domain in complex with a FxxLW motif |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T7F |
Crystal structure of the androgen receptor ligand binding domain in complex with a LxxLL motif |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T7M |
Crystal structure of the androgen receptor ligand binding domain in complex with a FxxYF motif |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T7R |
Crystal structure of the androgen receptor ligand binding domain in complex with a FxxLF motif |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1TFC |
CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE ESTROGEN-RELATED RECEPTOR GAMMA IN COMPLEX WITH A STEROID RECEPTOR COACTIVATOR-1 PEPTIDE |
D |
B |
Nuclear receptor ligand-binding domain |
|
 |
1U3R |
Crystal Structure of Estrogen Receptor beta complexed with WAY-338 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1U3S |
Crystal Structure of Estrogen Receptor beta complexed with WAY-797 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1U9E |
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-397 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1X76 |
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-697 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1X78 |
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-244 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1X7B |
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH ERB-041 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1X7J |
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH GENISTEIN |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1XB7 |
X-ray structure of ERRalpha LBD in complex with a PGC-1alpha peptide at 2.5A resolution |
P |
A |
Nuclear receptor ligand-binding domain |
|
 |
1XOW |
Crystal structure of the human androgen receptor ligand binding domain bound with an androgen receptor NH2-terminal peptide, AR20-30, and R1881 |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1YYE |
Crystal structure of estrogen receptor beta complexed with way-202196 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1ZGY |
Structural and Biochemical Basis for Selective Repression of the Orphan Nuclear Receptor LRH-1 by SHP |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
2AO6 |
Crystal structure of the human androgen receptor ligand binding domain bound with TIF2(iii) 740-753 peptide and R1881 |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
2FVJ |
A novel anti-adipogenic partial agonist of peroxisome proliferator-activated receptor-gamma (PPARG) recruits pparg-coactivator-1 alpha (PGC1A) but potentiates insulin signaling in vitro |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
2GPO |
Estrogen Related Receptor-gamma ligand binding domain complexed with a synthetic peptide from RIP140 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
2GTK |
Structure-based Design of Indole Propionic Acids as Novel PPARag CO-Agonists |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
2HFP |
Crystal Structure of PPAR Gamma with N-sulfonyl-2-indole carboxamide ligands |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
2J7X |
STRUCTURE OF ESTRADIOL-BOUND ESTROGEN RECEPTOR BETA LBD IN COMPLEX WITH LXXLL MOTIF FROM NCOA5 |
B |
A |
Nuclear receptor ligand-binding domain |
|